Business Description
Fortress Biotech Inc
NAICS : 325412
SIC : 2834
ISIN : US34960Q1094
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.86 | |||||
Equity-to-Asset | 0.12 | |||||
Debt-to-Equity | 4.95 | |||||
Debt-to-EBITDA | -0.95 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -8.22 | |||||
Beneish M-Score | -0.75 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.1 | |||||
3-Year EBITDA Growth Rate | 3.4 | |||||
3-Year EPS without NRI Growth Rate | 6.4 | |||||
3-Year FCF Growth Rate | 3.9 | |||||
3-Year Book Growth Rate | -54.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 31.58 | |||||
Future 3-5Y Total Revenue Growth Rate | 29.65 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 45 | |||||
14-Day RSI | 43.58 | |||||
6-1 Month Momentum % | -40.13 | |||||
12-1 Month Momentum % | -57.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.37 | |||||
Quick Ratio | 1.24 | |||||
Cash Ratio | 1.01 | |||||
Days Inventory | 151.83 | |||||
Days Sales Outstanding | 53.2 | |||||
Days Payable | 588.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -33.6 | |||||
Shareholder Yield % | -105.58 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 68.77 | |||||
Operating Margin % | -118.88 | |||||
Net Margin % | -49.25 | |||||
FCF Margin % | -119.2 | |||||
ROE % | -206.27 | |||||
ROA % | -25.14 | |||||
ROIC % | -146.04 | |||||
ROC (Joel Greenblatt) % | -440.07 | |||||
ROCE % | -149.47 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.11 | |||||
PB Ratio | 2.64 | |||||
EV-to-EBIT | -0.6 | |||||
EV-to-EBITDA | -0.64 | |||||
EV-to-Revenue | 0.73 | |||||
EV-to-Forward-Revenue | 0.54 | |||||
EV-to-FCF | -0.61 | |||||
Earnings Yield (Greenblatt) % | -166.67 | |||||
FCF Yield % | -207.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Fortress Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 76.679 | ||
EPS (TTM) (€) | -0.881 | ||
Beta | 0 | ||
Volatility % | 47.06 | ||
14-Day RSI | 43.58 | ||
14-Day ATR (€) | 0.000276 | ||
20-Day SMA (€) | 4.131 | ||
12-1 Month Momentum % | -57.25 | ||
52-Week Range (€) | 3.659999 - 11.675999 | ||
Shares Outstanding (Mil) | 18.38 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Fortress Biotech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Fortress Biotech Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Fortress Biotech Inc Frequently Asked Questions
What is Fortress Biotech Inc(FRA:CNB1)'s stock price today?
When is next earnings date of Fortress Biotech Inc(FRA:CNB1)?
Does Fortress Biotech Inc(FRA:CNB1) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |